19
Views
9
CrossRef citations to date
0
Altmetric
Original Paper

Co-administration of Caspofungin and Cyclosporine to a Kidney Transplant Patient with Pulmonary Aspergillus Infection

, &
Pages 894-895 | Received 07 Jul 2003, Accepted 14 Aug 2003, Published online: 08 Jul 2009

References

  • Wingard JR, Kubilis P, Lee I, Yee G, White M, Walshe L, et al. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis 1999; 29: 1402–7
  • Johnson LB, Kauffman C. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003; 36: 630–7
  • Sable C, Nguyen B-Y T, Chodakewitz JA, DiNubile MJ. Safety and tolerability of caspofungin acetate in the treatment of fungal infections. Transpl Infect Dis 2002; 4: 25–30.
  • Andriole VT. Current and future antifungal therapy: new targets for antifungal agents. J Antimicrob Chemother 1999; 44: 151–62.
  • Martinez-Suarez JV, Rodriguez-Tudela JL. In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates. Antimicrob Agents Chemother 1996; 40: 1277–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.